期刊文献+

1993~2003年辽宁地区入院诊疗的肺癌患者痰细胞学类型及变化趋势的分析 被引量:1

Analysis of tumor cytological types and their variation in sputum from lung cancer patients of out-patient and in-patient from 1993 to 2003 in Liaoning Province
下载PDF
导出
摘要 目的:探讨肺癌发病与年龄的关系,为肺癌防治提供依据。方法:采用PAT蓄痰液查瘤细胞方法.分析在中国医科大学附属第一医院门诊和住院的辽宁地区1993~2003年2251例肺癌患者细胞学类型。结果:2251例肺癌患者中,有684例(30.39%)检出瘤细胞,男、女的阳性率分别为32.02%(504/1574)和26.59%(180/677);684例痰阳性患者中,鳞癌、腺癌、小细胞癌及大细胞癌分别占57.65%、31.77%、8.21%和0.41%。各细胞学类型的变化趋势为:男性腺癌呈下降趋势(r=0.576,P≤0.05),鳞癌呈现下降趋势,但差异无统计学意义;女性腺癌呈上升趋势(r=0.563,P≤0.05),鳞癌呈现下降趋势,r=0.797,P≤0.01。40~79岁人群占所有肺癌患者的92.22%,其中50-79岁占80.55%。结论:鳞癌、腺癌和小细胞癌仍为肺癌的主要类型;女性鳞癌有下降的趋势,男性腺癌也有所下降,但女性腺癌有明显的上升趋势;40~79岁人群是肺癌的易患人群。 OBJECTIVE.. To investigate the tumor cytological types of sputum from lung cancer patients and their variation in recent 10 years and to show the relationship between the age and the prevalence rate of lung cancer. METHODS: By use PAT fixative solution, 2 251 lung cancer patients' of out-patient and in-pationt in First Affilia- ted Hospital of China Medical University sputum was collected and stained by HE to identify the tumor cytological types. RESULTS: The positive rate of tumor cells was 30. 39% in sputum of 684 out of 2 251 patients. The positive rates in men and women were 32.02%(504/1 574) and 26.59% (180/677), respectively. Among 684 positive patients, the proportions of squamous cell carcinoma, adenocarcinoma, small cell carcinoma and large cell carcinoma were 57.65%, 31.77%, 8.21% and 0.41%, respectively. The variation trends were., the proportion of adenocareinoma in men was decreased r= -0. 576, P≤0. 05), and that of squamous cell carcinoma in men was decreased without statistical significance; in women, the proportion of ad went up with year (r=0. 563,P≤0.05), and that of squamous cell carcinoma decreased, r= --0. 797,P≤0. 01. In all of patients, 40- to 79-year-old patients was 92.22%, and 50- to 79-years-old patients was 80. 55%. CONCLUSIONS: Squamous cell carcinoma, adenoear- cinoma and small cell carcinoma are principle types of lung cancer. Squamous cell carcinoma in women has the trend of going down by year. Adenocarcinoma in men goes down, but ad in women goes up obviously with the time. The group of 40-to 79-year-old was susceptible to lung cancer
出处 《中华肿瘤防治杂志》 CAS 2007年第5期328-331,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 肺肿瘤 辽宁 lung neoplasms sputum liaoning
  • 相关文献

参考文献10

  • 1Yang L,Parkin D M,Ferlay J,et al.Estimates of cancer incidence in China for 2000 and projections for 2005[J].Caner Epidemic Biomarkers Prev,2005,14(1):243-250.
  • 2何安光,曲恒春,刘江,刘可立,戴晓淳,李厚文,杨志山,殷洪年,胡永校.PAT蓄痰集检法对肺癌诊断的研究[J].中国医科大学学报,1990,19(5):365-368. 被引量:7
  • 3陆建峰,刘雷键,杨静宇,李士进,何安光,刘可立.一个用于肺癌早期诊断的彩色图像处理系统[J].高技术通讯,1997,7(3):17-20. 被引量:3
  • 4Williams M D,Sandler A B.The epidemiology of lung cancer[J].Cancer Treat Res,2001,105:31-52.
  • 5Sutedja G.New techniques for early detection of lung cancer[J].Eur Respir J,2003,39(Suppl):57-66.
  • 6Bach P B,Kelley M J,Tate R C,et al.Screening for lung cancer:a review of the current literature[J].Chest,2003,123(1 Suppl):72-82.
  • 7Tsou J A,Hagen J A,Carpenter C L,et al.DNA methylation analysis:a powerful new tool for lung cancer diagnosis[J].Oncogene,2002,21(35):5450-5461.
  • 8Sharp L,Brewster D.The epidemiology of lung cancer in Scotland:a review of trends in incidence,survival and mortality and prospects for prevention[J].Health Bull (Edinb),1999,57(5):318-331.
  • 9查清,陈永忠,杜应秀.广州市肺癌患者细胞学类型的变动趋势及分析[J].肿瘤,1996,16(5):512-516. 被引量:5
  • 10Koyi H,Hillerdal G,Branden E.A prospective study of a total material of lung cancer from a county in Sweden 1997-1999:gender,symptoms,type,stage,and smoking habits[J].Lung Cancer,2002,36(1):9-14.

二级参考文献5

  • 1夏祥新,肿癌,1987年,7卷,2期,80页
  • 2Lei L J,SPIE.2298,1994年
  • 3Lei L J,Advances In Modeling Analysis.B,1994年,29卷,4期,57页
  • 4Chen C H,SPIE.1192,1989年
  • 5郑苇,高玉堂,张溶,邓杰,孙璐,廖美琳,杨子培,林震琼,赵基津,张彦树.吸烟与肺鳞癌、肺腺癌关系的调查研究[J]肿瘤,1986(01).

共引文献11

同被引文献9

  • 1Non - small Cell Lung Cancer Collaborative Group. Chemotherapyin non - small cell lung cancer:a meta - analysis using updated da-ta on individual patients from 52 randomised clinical trials [ J ].BMJ,1995,311(7010) :899 -909.
  • 2Therasse P,Arbuck SG,Eisenhauer EA,et al. New guidelines to e-valuate the response to treatment in solid tumors. European organi-zation for research and treatment of cancer, national cancer instituteof the united states,national cancer institute of Canada[ J]. J NatlCancer Inst,2000,92(3) :205 -216.
  • 3Han SW,Hwang PG,Chung DH,et al. Epidermal growth factor re-ceptor (EGFR) downstream molecules as response predictivemarkers for gefitinib in chemotherapy - resistant non - small celllung cancer [ J]. Int J Cancer,2005 ,113( 1 ) :109 - 115.
  • 4Thatcher N,Chang A,Parikh P,et al. Gefitinib plus Kest supportivecare in previously treated patients with refractory advanced non -small cell lung cancer : result from a randomized,placedbo con-trolled ,multticentre study (iressa survival evaluation in lung canc-er) [J]. Lancet,2005 ,366(9496) :1527 -1537.
  • 5Jiang J,Huang L,Liang X,et al. Gefitinib versus docetaxel in previ-ously treated advanced non - small cell lung cancer: a meta - anal-ysis of randomized controlled trials[ J]. Acta Oncol,2011,50(4);582 -588.
  • 6TOK TS, WU YL,Thongpasert S, et al. Gefitinib or carboplatin -paclitaxel in pulmonary adenocarcinoma [ J ]. N Engl J Med,2009,61(10):947 -957.
  • 7Rosell R,Moran T,Queralt C,et al. Screening for epidermal growthfactor receptor mutations in lung cancer [ J ]. N Engl J Med, 2009,361(10):958 -967.
  • 8朱利娜,杨振君,王士勇.吉非替尼治疗晚期非小细胞肺癌研究进展[J].中国肺癌杂志,2009,12(5):432-439. 被引量:3
  • 9安彤同,黄真,王玉艳,王志杰,白桦,王洁.晚期非小细胞肺癌初始治疗后再次应用EGFR-TKI的疗效观察[J].中国肺癌杂志,2011,14(3):261-265. 被引量:11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部